| Nicholas Christofidis, APRN, FNP-C | |
|
25495 Main St, Ardmore, TN 38449-3155 | |
| (931) 427-6969 | |
| (931) 427-6967 |
| Full Name | Nicholas Christofidis |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 25495 Main St, Ardmore, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760878185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APN 19810 (Tennessee) | Primary |
| Entity Name | Deborah Verbeek |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194835645 PECOS PAC ID: 7012949746 Enrollment ID: O20090814000472 |
News Archive
Closing schools for less than two weeks during a flu pandemic may increase infection rates and prolong an epidemic, say University of Pittsburgh researchers in a study published ahead-of-print and online in the Journal of Public Health Management and Practice.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
Advanced age is not a reason to preclude patients from receiving vascular endothelial growth factor-targeted therapy for metastatic renal cell carcinoma, show study findings from a mixed-age patient population.
Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Christofidis, APRN, FNP-C 25495 Main St, Ardmore, TN 38449-3155 Ph: (931) 427-6969 | Nicholas Christofidis, APRN, FNP-C 25495 Main St, Ardmore, TN 38449-3155 Ph: (931) 427-6969 |
News Archive
Closing schools for less than two weeks during a flu pandemic may increase infection rates and prolong an epidemic, say University of Pittsburgh researchers in a study published ahead-of-print and online in the Journal of Public Health Management and Practice.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
Advanced age is not a reason to preclude patients from receiving vascular endothelial growth factor-targeted therapy for metastatic renal cell carcinoma, show study findings from a mixed-age patient population.
Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.
› Verified 1 days ago
Deborah Ruth Verbeek, CFNP, MSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25495 Main St, Ardmore, TN 38449 Phone: 931-427-6969 Fax: 931-427-6967 | |
Serena Proudfoot, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 26150 Main St, Ardmore, TN 38449 Phone: 931-207-9297 Fax: 931-209-9298 | |
Diego Alejandro Cacho-tovar, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26150 Main St, Ardmore, TN 38449 Phone: 931-207-9297 Fax: 931-209-9298 |